You need to be logged in to view this content. Simple Membership is not configured correctly. The login page or the join us page URL is missing in the settings configuration. Please contact Admin
Focus Area: Quality & Transparency
Bioethics Collaborative Info Sheet 2017
Info Sheet
Published on: November 2017
Developed by: MRCT Center
Impact of Social Media on Clinical Trial Integrity
Meeting Summary
Released on: January 22, 2019
Developed by: MRCT Center Bioethics Collaborative
Data sharing in the context of community-engaged research partnerships
Publication
Published on: May, 2023
Published in: Social Science & Medicine
Description: As data sharing is expanded in the context of greater community engagement in research, we must ask to whom do benefits of data sharing accrue and to whom do benefits not accrue? In an era of growing efforts to engage diverse communities in research, the impact of data sharing for all research participants and the communities that they represent requires the reassessment of the principles of data sharing, incorporating principles of community-engaged research. This article outlines these considerations and proposes new models of benefit sharing.
Enabling Informed Selection of Clinical Trials
Data Safety Monitoring Board Training Videos
Presentation
Presented on: May 19, 2013
Presented at: Workshops at the Society for Clinical Trials Annual Meeting, Boston
Disclosure of Possible Trial Termination to Participants of Interventional Clinical Trials
Publication
Published on: April 4, 2023
Published in: JAMA
Trial termination (the decision to end a trial earlier than planned) has been reported in 17.9% of cardiovascular trials and 16.0% of surgical trials.1,2 Although some trials are terminated for scientific reasons due to safety, efficacy, or futility, many trials are terminated due to inadequate participant enrollment or other nonscientific reasons.
2021 MRCT Center Impact Report
Annual Report
Presented on: December 7, 2021
Presented at: MRCT Annual Meeting
2018 MRCT Center Impact Report
Annual Report
Presented on: December 5, 2018
Presented at: Harvard Faculty Club, Loeb House
Diagnostic Testing for COVID-19: Considering False Positive and False Negative Results by Deborah A. Zarin, MD, MRCT Center Program Director and Joseph Lau, MD
Publication
Published on: April, 2020
Diagnostic tests for COVID-19 are central to most proposed plans for relaxing physical distancing and related policies. The following work by Deborah A. Zarin, MD MRCT Center Program Director and Joseph Lau, MD ,Professor Emeritus of Health Services, Policy and Practice, Center for Evidence Synthesis in Health, Brown University School of Public Health serves as a reminder about what we know and don’t know about these tests, how frequently they might produce inaccurate results, and how these inaccuracies might affect their utility in different potential scenarios.
